Track topics on Twitter Track topics that are important to you
Recro Pharma has unveiled positive results from its second of two Phase III clinical trials assessing intravenous (IV) meloxicam for the treatment of acute postoperative pain.
Recro Pharma Inc. (NASDAQ:REPH) gained $1.54 (20%) to $9.30 after it said IV meloxicam (N1539) met the primary endpoint of a second Phase III study to treat acute postoperative pain. The therapy signi...
This study determined whether meloxicam in nanocapsules modifies stomach and liver damage caused by free meloxicam in mice. Male Swiss mice were treated with blank nanocapsules or meloxicam in nanocap...
Immediate postoperative evaluation of enteric anastomosis after the use of meloxicam in ratsFellow Master degree, Postgraduate Program in Animal Sciences, Pontificia Universidade Católica do Paraná (PUCPR), Curitiba-PR, Brazil. Acquisition, analysis and interpretation of data; manuscript writing., Pontifícia Universidade Católica do Paraná, Pontificia Universidade Católica do Paraná, Curiti
To compare ileal anastomoses in the immediate postoperative healing period after meloxicam use.
Considering that Alzheimer's disease is a prevalent neurodegenerative disease worldwide, we investigated the activities of three key kinases: creatine kinase, pyruvate kinase and adenylate kinase in t...
Dry powder inhalers (DPIs) have been among the fastest developing inhaler forms in the past decades. Researches are focusing on the formulation of carrier-free powders to obtain a higher deep-lung dep...